Last reviewed · How we verify

NCT06817538

Investigation of the Effects of Dual Task Training on Dual Task Performance in Individuals With Scoliosis

Completed NA Last updated 15 April 2025
What this trial tests

NA trial testing Physiotherapy/Exercise Program in Idiopathic Scoliosis in 38 participants. Completed in 31 March 2025.

Timeline
31 December 2024
Primary endpoint
30 March 2025
31 March 2025

Quick facts

Lead sponsorHacettepe University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment38
Start date31 December 2024
Primary completion30 March 2025
Estimated completion31 March 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 10 to 18, any sex, with Idiopathic Scoliosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, "Single Task" and "Dual Task" groups will be formed in individuals aged 10-18 years with scoliosis. For 12 weeks, scoliosis-specific three-dimensional exercises will be applied to both groups. The Single Task group will receive only motor exercise training, while the Dual Task group will receive both motor and cognitive exercise training. At the end of the study, the dual-task performance of both groups will be evaluated and the effects of dual task training on individuals with scoliosis will be analyzed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Idiopathic Scoliosis

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06817538.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing